Your browser is no longer supported. Please, upgrade your browser.
Settings
HZNP [NASD]
Horizon Therapeutics Public Limited Company
Index- P/E81.42 EPS (ttm)1.15 Insider Own0.80% Shs Outstand223.92M Perf Week1.43%
Market Cap20.55B Forward P/E18.36 EPS next Y5.11 Insider Trans-30.49% Shs Float219.76M Perf Month-1.02%
Income280.00M PEG5.82 EPS next Q0.88 Inst Own90.30% Short Float2.58% Perf Quarter3.87%
Sales2.19B P/S9.40 EPS this Y-37.60% Inst Trans-0.38% Short Ratio3.34 Perf Half Y35.45%
Book/sh17.21 P/B5.45 EPS next Y39.23% ROA4.60% Target Price114.18 Perf Year87.87%
Cash/sh3.71 P/C25.32 EPS next 5Y14.00% ROE8.00% 52W Range48.98 - 97.36 Perf YTD28.34%
Dividend- P/FCF37.68 EPS past 5Y48.20% ROI8.90% 52W High-3.57% Beta1.10
Dividend %- Quick Ratio2.10 Sales past 5Y23.80% Gross Margin75.50% 52W Low91.67% ATR2.87
Employees1640 Current Ratio2.40 Sales Q/Q-3.80% Oper. Margin14.40% RSI (14)56.32 Volatility3.47% 3.07%
OptionableYes Debt/Eq0.67 EPS Q/Q-670.40% Profit Margin12.80% Rel Volume1.21 Prev Close94.61
ShortableYes LT Debt/Eq0.66 EarningsMay 05 BMO Payout0.00% Avg Volume1.69M Price93.88
Recom1.60 SMA202.24% SMA502.26% SMA20014.03% Volume2,048,673 Change-0.77%
Mar-22-21Resumed Morgan Stanley Overweight $103
Mar-12-21Initiated Wolfe Research Outperform $107
Sep-09-20Initiated JP Morgan Overweight $110
Aug-27-20Initiated Citigroup Buy $112
Jan-08-20Initiated Goldman Neutral $35
Sep-26-19Initiated BofA/Merrill Buy $34
Sep-12-19Initiated Guggenheim Buy
Aug-14-19Upgrade BMO Capital Markets Market Perform → Outperform $29 → $36
May-01-19Upgrade Citigroup Neutral → Buy $21 → $32
Mar-08-19Upgrade Morgan Stanley Equal-Weight → Overweight $32
Nov-15-18Downgrade Mizuho Buy → Neutral
Jun-27-18Downgrade Citigroup Buy → Neutral
Jan-12-18Upgrade Mizuho Neutral → Buy $12 → $18
Sep-28-17Initiated Goldman Buy $16
Jun-16-17Initiated Cantor Fitzgerald Overweight $13
May-09-17Reiterated Stifel Buy $35 → $20
May-09-17Downgrade Mizuho Buy → Neutral $22 → $10
Feb-28-17Reiterated Mizuho Buy $25 → $22
Dec-16-16Upgrade Mizuho Neutral → Buy $14 → $25
Dec-09-16Downgrade Mizuho Buy → Neutral $30 → $14
Jun-21-21 12:58PM  
07:30AM  
Jun-18-21 12:30PM  
Jun-17-21 07:00AM  
Jun-08-21 04:14AM  
Jun-02-21 08:00AM  
May-27-21 08:00AM  
May-24-21 08:00AM  
May-21-21 08:00AM  
May-20-21 08:30AM  
May-13-21 11:30AM  
May-06-21 04:30PM  
08:30AM  
08:00AM  
May-05-21 12:53PM  
07:00AM  
May-04-21 01:59PM  
Apr-27-21 08:00AM  
Apr-24-21 04:44AM  
Apr-22-21 04:49PM  
Apr-21-21 07:30AM  
Apr-17-21 06:33AM  
Apr-16-21 08:30AM  
08:00AM  
Apr-12-21 03:58PM  
08:30AM  
Apr-08-21 08:00AM  
Apr-07-21 08:00AM  
Apr-05-21 08:30AM  
Mar-30-21 07:30AM  
Mar-29-21 10:05AM  
Mar-25-21 01:26PM  
08:00AM  
Mar-24-21 08:15AM  
08:00AM  
Mar-23-21 11:18AM  
Mar-22-21 04:23AM  
Mar-17-21 01:10PM  
Mar-16-21 07:35AM  
Mar-15-21 03:37PM  
01:05PM  
08:50AM  
Mar-12-21 08:45AM  
Mar-11-21 04:51PM  
03:00AM  
Mar-10-21 01:36PM  
Mar-09-21 01:16PM  
09:40AM  
Mar-08-21 09:53AM  
Feb-26-21 04:05PM  
Feb-25-21 04:05PM  
03:27PM  
12:03PM  
Feb-24-21 04:41PM  
11:01AM  
07:00AM  
Feb-22-21 09:30AM  
Feb-20-21 08:33PM  
Feb-18-21 01:08PM  
Feb-17-21 12:44PM  
Feb-10-21 01:40PM  
Feb-04-21 01:54PM  
Feb-03-21 12:53PM  
08:00AM  
Feb-02-21 07:40AM  
Feb-01-21 03:12PM  
02:57PM  
02:05PM  
09:36AM  
07:27AM  
07:00AM  
Jan-26-21 03:39PM  
01:42PM  
Jan-20-21 12:45PM  
Jan-18-21 08:46PM  
Jan-11-21 07:00AM  
Jan-08-21 02:23AM  
Jan-05-21 06:00AM  
Dec-22-20 08:00AM  
Dec-17-20 06:40AM  
Dec-15-20 04:13PM  
10:40AM  
Dec-14-20 01:58PM  
Dec-09-20 10:42AM  
Dec-07-20 01:57PM  
01:11PM  
10:56AM  
Dec-03-20 09:00AM  
Dec-02-20 09:15AM  
Dec-01-20 02:22AM  
Nov-30-20 08:00AM  
Nov-25-20 08:00AM  
Nov-23-20 08:00AM  
08:00AM  
Nov-18-20 10:11AM  
Nov-17-20 09:15AM  
Nov-16-20 10:54AM  
Nov-13-20 10:40AM  
10:31AM  
08:30AM  
Horizon Therapeutics Public Limited Company focuses on researching, developing, and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally. It operates in two segments, Orphan and Inflammation. Its medicines include KRYSTEXXA, a medicine for the treatment of uncontrolled gout; RAVICTI for use as a nitrogen-binding agent for chronic management of adult and pediatric patients; PROCYSBI for nephropathic cystinosis, a rare lysosomal storage disorder; ACTIMMUNE for chronic granulomatous disease and severe malignant osteopetrosis; RAYOS for the treatment of rheumatoid arthritis (RA), ankylosing spondylitis (AS), polymyalgia rheumatica, primary systemic amyloidosis, asthma, chronic obstructive pulmonary disease, systemic lupus erythematosus, and other conditions; BUPHENYL tablets for oral administration and BUPHENYL powder for oral, nasogastric, or gastrostomy tube administration; and QUINSAIR, a formulation of the antibiotic drug levofloxacin for the management of chronic pulmonary infections due to Pseudomonas aeruginosa in adult patients with cystic fibrosis. The company also offers PENNSAID 2% that is indicated for the treatment of pain of osteoarthritis (OA) of the knees; DUEXIS for the relief of signs and symptoms of RA and OA, and to decrease the risk of developing upper-GI ulcers; and VIMOVO for the relief of signs and symptoms of OA, RA, and AS to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. It has collaboration agreements with Lupus Research and HemoShear Therapeutics, LLC. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walbert Timothy PChairman, President and CEOJun 01Sale91.8525,0002,296,204875,887Jun 03 04:41 PM
Hoelscher Paul W.EVP, CFOMay 14Sale90.01102,9259,263,847172,226May 14 06:12 PM
Kent JeffSee remarksMay 11Option Exercise22.1412,592278,78783,586May 12 05:02 PM
Daniel William FDirectorMay 10Option Exercise12.7020,000254,00020,000May 12 05:01 PM
Daniel William FDirectorMay 10Sale86.5620,0001,731,2750May 12 05:01 PM
Walbert Timothy PChairman, President and CEOApr 30Sale94.9825,0002,374,413899,838Apr 30 07:03 PM
GREY MICHAEL GDirectorApr 12Option Exercise2.3715,00035,55015,000Apr 13 06:03 PM
MOZE BARRYEVP, Chief Admin. OfficerApr 12Sale88.9665,6135,837,049105,665Apr 13 06:04 PM
GREY MICHAEL GDirectorApr 12Sale90.2815,0001,354,2000Apr 13 06:03 PM
Camardo Daniel A.EVP and President, U.S.Apr 05Option Exercise24.1818,281442,09351,181Apr 05 05:25 PM
CURTIS GEOFFREY M.EVP, Corporate Affairs, CCOApr 01Option Exercise28.4037,0001,050,710123,414Apr 02 05:13 PM
CURTIS GEOFFREY M.EVP, Corporate Affairs, CCOApr 01Sale93.5170,7396,615,09452,675Apr 02 05:13 PM
Beeler Brian KEVP, General CounselMar 31Sale90.1226,8442,419,18195,677Apr 02 05:11 PM
Camardo Daniel A.EVP and President, U.S.Mar 30Sale85.5012,9001,103,00632,900Mar 31 05:11 PM
Shannon James SamuelDirectorMar 01Option Exercise12.197,23288,1587,232Mar 03 04:46 PM
Shannon James SamuelDirectorMar 01Sale91.307,232660,2610Mar 03 04:46 PM
Walbert Timothy PChairman, President and CEOMar 01Sale91.3526,9752,464,137924,838Mar 03 04:44 PM
SANTINI GINODirectorMar 01Sale91.4712,0001,097,60023,795Mar 03 04:45 PM
DesJardin Michael A.EVP, Technical OperationsFeb 26Sale91.831,099100,92186,247Feb 26 06:12 PM
DesJardin Michael A.EVP, Technical OperationsFeb 24Sale92.4815,9441,474,44887,346Feb 26 06:12 PM
Konstantinovsky IrinaEVP, Chief Human Resources OffFeb 22Sale87.225,698496,98781,677Feb 23 06:19 PM
Karnani VikramEVP & President, InternationalFeb 22Sale87.198,358728,722104,165Feb 23 06:20 PM
DesJardin Michael A.EVP, Technical OperationsFeb 11Sale90.0010,786970,740101,200Feb 12 05:01 PM
DesJardin Michael A.EVP, Technical OperationsFeb 02Sale85.004,530385,050111,986Feb 04 05:39 PM
Walbert Timothy PChairman, President and CEOFeb 01Option Exercise0.009,087022,895Feb 03 05:24 PM
Karnani VikramEVP & President, InternationalJan 22Sale76.812,731209,768111,429Jan 22 09:05 PM
Konstantinovsky IrinaEVP, Chief Human Resources OffJan 22Sale76.812,226170,97986,500Jan 22 09:04 PM
Walbert Timothy PChairman, President and CEOJan 22Sale76.4711,323865,917946,559Jan 22 08:59 PM
Camardo Daniel A.EVP and President, U.S.Jan 21Option Exercise0.003,220046,503Jan 22 09:09 PM
Beeler Brian KEVP, General CounselJan 21Option Exercise0.004,1200123,472Jan 22 09:08 PM
McHugh Miles WSr VP & Princ. Acctg OfficerJan 21Option Exercise0.003,590035,206Jan 22 09:08 PM
DesJardin Michael A.EVP, Technical OperationsJan 21Option Exercise0.003,6780118,340Jan 22 09:06 PM
CURTIS GEOFFREY M.EVP, Corporate Affairs, CCOJan 21Option Exercise0.003,760087,205Jan 22 09:07 PM
Karnani VikramEVP & President, InternationalJan 21Option Exercise0.004,9040116,333Jan 22 09:05 PM
Konstantinovsky IrinaEVP, Chief Human Resources OffJan 21Option Exercise0.003,999090,498Jan 22 09:04 PM
MOZE BARRYEVP, Chief Admin. OfficerJan 21Option Exercise0.005,8190172,762Jan 22 09:03 PM
Kent JeffSee remarksJan 21Option Exercise0.003,045071,468Jan 22 09:02 PM
Hoelscher Paul W.EVP, CFOJan 21Option Exercise0.005,55606,605Jan 22 09:01 PM
Walbert Timothy PChairman, President and CEOJan 21Option Exercise0.002,575014,563Jan 22 08:59 PM
Walbert Timothy PChairman, President and CEOJan 21Option Exercise0.0020,3300966,889Jan 22 08:59 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerJan 21Option Exercise0.005,353081,361Jan 22 09:00 PM
Walbert Timothy PChairman, President and CEOJan 15Sale77.89211,20416,449,893946,559Jan 15 05:43 PM
DesJardin Michael A.EVP, Technical OperationsJan 06Option Exercise16.3527,106443,296141,768Jan 08 05:32 PM
Konstantinovsky IrinaEVP, Chief Human Resources OffJan 06Sale74.7626,8442,006,85486,499Jan 08 05:33 PM
Karnani VikramEVP & President, InternationalJan 06Sale75.0030,0312,252,325111,429Jan 08 05:31 PM
DesJardin Michael A.EVP, Technical OperationsJan 06Sale75.0027,1062,032,950114,662Jan 08 05:32 PM
McHugh Miles WSr VP & Princ. Acctg OfficerDec 14Sale80.001,856148,48019,741Dec 15 05:00 PM
DesJardin Michael A.EVP, Technical OperationsDec 10Sale69.645,909411,50363,392Dec 11 04:41 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerDec 08Sale71.1540,7642,900,354174,955Dec 09 05:05 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerDec 07Sale70.9463,0784,474,860215,719Dec 09 05:05 PM
McHugh Miles WSr VP & Princ. Acctg OfficerNov 12Sale75.4812,124915,12021,597Nov 13 07:27 PM
Camardo Daniel A.EVP and President, U.S.Nov 06Sale76.763,500268,66330,829Nov 06 06:00 PM
Kent JeffSee remarksNov 05Sale78.9447,9443,784,66351,049Nov 06 06:00 PM
MOZE BARRYEVP, Chief Admin. OfficerNov 05Sale78.9377,5006,117,259100,709Nov 06 06:00 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerOct 21Option Exercise7.6113,00098,93028,015Oct 21 05:06 PM
Konstantinovsky IrinaEVP, Chief Human Resources OffSep 17Option Exercise14.0521,351299,98257,373Sep 18 05:00 PM
Konstantinovsky IrinaEVP, Chief Human Resources OffSep 16Sale78.888,919703,53136,022Sep 18 05:00 PM
Beeler Brian KEVP, General CounselSep 04Option Exercise14.9128,143419,66664,028Sep 08 04:51 PM
Hoelscher Paul W.EVP, CFOAug 24Sale75.7629,5762,240,702102,925Aug 25 05:16 PM
Walbert Timothy PChairman, President and CEOAug 06Sale72.54110,0007,979,414733,792Aug 07 05:42 PM
GREY MICHAEL GDirectorAug 05Option Exercise3.951,7556,9321,755Aug 07 05:40 PM
GREY MICHAEL GDirectorAug 05Sale73.351,755128,7290Aug 07 05:40 PM
Karnani VikramEVP & President, InternationalAug 03Option Exercise13.1536,772483,63678,941Aug 05 01:24 PM
SANTINI GINODirectorAug 03Option Exercise2.8835,795103,26235,795Aug 04 04:56 PM
GREY MICHAEL GDirectorJul 22Option Exercise3.951,7556,9321,755Jul 22 05:33 PM
GREY MICHAEL GDirectorJul 22Sale60.001,755105,3000Jul 22 05:33 PM
Kent JeffSee remarksJul 07Option Exercise5.6838,000215,98098,993Jul 07 06:57 PM
MOZE BARRYEVP, Chief Admin. OfficerJul 07Option Exercise13.1735,076461,918178,209Jul 07 06:50 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerJul 06Sale57.509,100523,250278,797Jul 07 06:49 PM
MOZE BARRYEVP, Chief Admin. OfficerJul 01Sale54.6423,1581,265,441143,133Jul 02 04:46 PM
GREY MICHAEL GDirectorJun 25Option Exercise3.951,7556,9321,755Jun 26 05:00 PM
GREY MICHAEL GDirectorJun 25Sale55.001,75596,5250Jun 26 05:00 PM